Publications by authors named "Kay Davies"

Claim this Profile
R
Retraction notice to "Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial" [J. Clin. Virol. 155C (2022) 105248].
Damian Balmforth, James A Swales, Laurence Silpa, Alan Dunton, Kay E Davies, Stephen G Davies

J Clin Virol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal journeys to and in human genetics and dysmorphology.
Charles E Schwartz, Arthur S Aylsworth, Judith Allanson, Agatino Battaglia, John C Carey, Kay E Davies

Am J Med Genet A· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene.
Kay E Davies, Julie Vogt

Neuromuscul Disord· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene" Neuromuscular Disorders 39 (2024) 5-9.
Kay E Davies, Julie Vogt

Neuromuscul Disord· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approaches for Duchenne muscular dystrophy.
Thomas C Roberts, Matthew J A Wood, Kay E Davies

Nat Rev Drug Discov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utrophin correlates with disease severity in Duchenne muscular dystrophy.
Simon Guiraud, Kay Davies

Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RETRACTED: Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.
Damian Balmforth, James A Swales, Laurence Silpa, Alan Dunton, Kay E Davies, Stephen G Davies

J Clin Virol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Maria Chatzopoulou, Daniel Conole, Enrico Emer, Jessica A Rowley, Nicky J Willis, Stephen G Davies, Kay E Davies

Bioorg Med Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
Katharina E Meijboom, Emma R Sutton, Eve McCallion, Emily McFall, Daniel Anthony, Kay E Davies

Skelet Muscle· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.
Pachamuthu Kandasamy, Graham McClorey, Mamoru Shimizu, Nayantara Kothari, Rowshon Alam, Kay E Davies

Nucleic Acids Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues.
Gauri Ang, Laurence A Brown, Shu K E Tam, Kay E Davies, Russell G Foster

Transl Psychiatry· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Happy 30th Birthday, HMG.
Kay E Davies

Hum Mol Genet· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy.
Vratko Himič, Kay E Davies

Eur J Hum Genet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy.
Aini Vuorinen, Isabel V L Wilkinson, Maria Chatzopoulou, Ben Edwards, Sarah E Squire, Stephen G Davies, Kay E Davies

Eur J Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary genomics in Africa.
Michèle Ramsay, Carina Schlebusch, Kay Davies

Hum Mol Genet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journals.
Jan Higgins, Raymond Dalgleish, Johan T den Dunnen, Greg Barsh, Peter J Freeman, Kay E Davies

Hum Mutat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.
Maria Chatzopoulou, Enrico Emer, Cristina Lecci, Jessica A Rowley, Anne-Sophie Casagrande, Stephen G Davies, Kay E Davies

ACS Med Chem Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations of neuromuscular junctions in Duchenne muscular dystrophy.
Richard M Lovering, Shama R Iyer, Benjamin Edwards, Kay E Davies

Neurosci Lett· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highway to HHGE: An Interview with Dame Kay E. Davies.
Kevin Davies, Kay E Davies

CRISPR J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long Journey from Diagnosis to Therapy.
Kay E Davies

Annu Rev Genomics Hum Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Arylbenzo[]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.
Arran Babbs, Adam Berg, Maria Chatzopoulou, Kay E Davies, Stephen G Davies

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From diagnosis to therapy in Duchenne muscular dystrophy.
Arran Babbs, Maria Chatzopoulou, Ben Edwards, Sarah E Squire, Isabel V L Wilkinson, Kay E Davies

Biochem Soc Trans· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, Philip J Brooks, Kristina Larsson, Kay Davies

Nat Rev Drug Discov· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, Philip J Brooks, Kristina Larsson, Kay Davies

Nat Rev Drug Discov· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of SMT022357 enantiomers and evaluation in a Duchenne muscular dystrophy mouse model.
Arran Babbs, Adam Berg, Maria Chatzopoulou, Kay E Davies, Stephen G Davies

Tetrahedron· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis